| scholarly article | Q13442814 |
| P2093 | author name string | Ning Xu | |
| Xiao Ping Huang | |||
| Gui Fang Ouyang | |||
| Zhuan Bo Luo | |||
| P2860 | cites work | Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia | Q29547900 |
| Interstitial pneumonitis in a patient with chronic myeloid leukemia | Q42122505 | ||
| Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection | Q42339429 | ||
| Imatinib-induced dose-dependent interstitial lung disease successfully switched to nilotinib: a case report with concentration exposure data. | Q45162054 | ||
| Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinib. | Q51802507 | ||
| Twenty-seven cases of drug-induced interstitial lung disease associated with imatinib mesylate. | Q53543746 | ||
| Lack of recurrence of imatinib-induced interstitial lung disease with nilotinib. | Q54569183 | ||
| Lung Abnormalities after Dasatinib Treatment for Chronic Myeloid Leukemia | Q59640192 | ||
| P433 | issue | 4 | |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| P304 | page(s) | 362-364 | |
| P577 | publication date | 2017-07-28 | |
| P1433 | published in | Turkish journal of hematology : official journal of Turkish Society of Haematology | Q26842860 |
| P1476 | title | Imatinib-induced interstitial pneumonitis successfully switched to nilotinib in a patient with prior history of Mycobacterium tuberculosis infection | |
| P478 | volume | 34 |
Search more.